Skip to content

Clinical trials

Observational Cardiovascular Diseases trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Observational Country / region: Netherlands Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20071
20092
20101
20113
20125
20131
20145
20155
20161
20174
20184
20197
20204
20211
20222
20235
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Unknown status14
Recruiting11
Active, not recruiting7
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center8
UMC Utrecht7
Maastricht University Medical Center3
The Netherlands Cancer Institute3
Abbott Medical Devices2
Boston Scientific Corporation2
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)2
Institut für Pharmakologie und Präventive Medizin2
University Medical Center Groningen2
Academic Centre for Dentistry in Amsterdam1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases59
Atherosclerosis9
Heart Diseases6
Coronary Artery Disease5
Hypertension5
Myocardial Infarction5
Thrombosis5
Diabetes Mellitus4
Diabetes Mellitus, Type 24
Heart Failure4

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.